Fig. 2From: The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort studyCumulative incidence of ipsilateral (a) and contralateral (b) invasive breast cancer by method of detection, with death analyzed as a competing risk. P values based on competing risk regression with time since diagnosis of ductal carcinoma in situ as the primary time scale, adjusted for age (continuous) [25]Back to article page